Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Surmodics Inc
(NQ:
SRDX
)
41.95
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Surmodics Inc
< Previous
1
2
3
Next >
Surmodics to Participate in the 22nd Annual Needham Virtual Healthcare Conference on April 20
April 11, 2023
From
Surmodics, Inc.
Via
Business Wire
Surmodics, Inc. (NASDAQ:SRDX) Shareholder Alert: Investigation Concerning Possible Wrongdoing
April 05, 2023
San Diego, CA -- (SBWIRE) -- 04/05/2023 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Surmodics, Inc.
Via
SBWire
Surmodics Provides Regulatory Update on its Strategy to Submit an Amended Premarket Approval Application for the SurVeil™ Drug-Coated Balloon
March 28, 2023
From
Surmodics, Inc.
Via
Business Wire
Sidoti's Small-Cap Virtual March Conference
March 20, 2023
Via
ACCESSWIRE
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation - SRDX
March 18, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
Product Safety
ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation - SRDX
March 12, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
Product Safety
ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation – SRDX
March 09, 2023
From
The Rosen Law Firm PA
Via
GlobeNewswire
Surmodics to Participate in Upcoming Investor Conferences in March
March 08, 2023
From
Surmodics, Inc.
Via
Business Wire
NATIONALLY RANKED ROSEN LAW FIRM Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation - SRDX
March 05, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
Product Safety
SRDX NOTICE: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation – SRDX
March 03, 2023
From
The Rosen Law Firm PA
Via
GlobeNewswire
ROSEN, A TOP RANKED LAW FIRM, Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation - SRDX
February 26, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
Product Safety
ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation – SRDX
February 23, 2023
From
The Rosen Law Firm PA
Via
GlobeNewswire
ROSEN, A LEADING LAW FIRM, Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation - SRDX
February 19, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
Product Safety
NATIONALLY RANKED ROSEN LAW FIRM Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation – SRDX
February 09, 2023
From
The Rosen Law Firm PA
Via
GlobeNewswire
Surmodics, Inc. (NASDAQ:SRDX) Investor Alert: Investigation over Possible Violations of Securities Laws
February 07, 2023
San Diego, CA -- (SBWIRE) -- 02/07/2023 -- An investigation was announced over potential securities laws violations by Surmodics, Inc. in connection with certain financial statements.
Via
SBWire
Surmodics Reports First Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance
February 06, 2023
From
Surmodics, Inc.
Via
Business Wire
Surmodics to Host Virtual Annual Meeting of Shareholders
January 31, 2023
From
Surmodics, Inc.
Via
Business Wire
Surmodics to Report First Quarter of Fiscal 2023 Financial Results on February 6
January 26, 2023
From
Surmodics, Inc.
Via
Business Wire
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Surmodics, Inc. and Encourages Investors with Losses to Contact the Firm
January 23, 2023
From
The Schall Law Firm
Via
Business Wire
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Surmodics, Inc. and Encourages Investors with Losses to Contact the Firm
January 20, 2023
From
The Schall Law Firm
Via
Business Wire
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Surmodics, Inc. (SRDX) Investigation
January 20, 2023
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
SRDX EQUITY ALERT: Rosen Law Firm Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation – SRDX
January 19, 2023
From
Rosen Law Firm
Via
Business Wire
Differentiated Capabilities of Surmodics’ Crystalline Drug Release Platform for Sirolimus-Coated Balloons Presented at ISET Conference
January 19, 2023
From
Surmodics, Inc.
Via
Business Wire
Surmodics Provides Regulatory Update Related to its FDA Premarket Approval Application for the SurVeil™ Drug-Coated Balloon
January 19, 2023
From
Surmodics, Inc.
Via
Business Wire
Surmodics Announces SWING Trial 12-Month Data to be Presented at ISET Conference on January 18
January 16, 2023
From
Surmodics, Inc.
Via
Business Wire
Surmodics Announces 12-Month Data from the SWING Trial Presented at VEITHsymposium
November 17, 2022
From
Surmodics, Inc.
Via
Business Wire
Surmodics Announces SWING Trial 12-Month Data to be Presented at VEITHsymposium on November 16
November 11, 2022
From
Surmodics, Inc.
Via
Business Wire
Surmodics Reports Fourth Quarter and Fiscal Year 2022 Financial Results; Introduces Fiscal Year 2023 Financial Guidance
November 09, 2022
From
Surmodics, Inc.
Via
Business Wire
24-Month Data from Surmodics’ TRANSCEND Trial Presented at VIVA 2022 Conference
November 02, 2022
From
Surmodics, Inc.
Via
Business Wire
Surmodics to Report Fourth Quarter and Fiscal Year 2022 Financial Results on November 9th
October 28, 2022
From
Surmodics, Inc.
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.